Cradle, which uses AI to help design proteins and says its SaaS model has proven popular, raised a $73M Series B led by IVP, after a $24M Series A in 2023 — Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and new investment.
Posted from: this blog via Microsoft Power Automate.